US Stock MarketDetailed Quotes

TARO Taro Pharmaceutical Industries

Watchlist

42.380
+0.050+0.12%

Trading May 15 09:30 ET

1.59BMarket Cap34.74P/E (TTM)

Taro Pharmaceutical Industries Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

(FY)Mar 31, 2022

(Q4)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

142.23%30.93M

133.37%47.52M

113.40%7.78M

120.01%31.75M

37.31%56.65M

106.65%12.77M

139.14%20.36M

-231.90%-58.03M

-446.73%-158.7M

-19.19%41.26M

Net income from continuing operations

178.08%20.21M

403.87%8.55M

-28.74%10.03M

-56.33%25.45M

-74.78%6.91M

-72.38%7.27M

-112.06%-2.81M

175.02%14.08M

114.54%58.27M

194.88%27.4M

Operating gains losses

-416.67%-741K

89.03%1.16M

-231.81%-953K

714.58%2.4M

327.52%835K

135.19%234K

-56.36%611K

195.26%723K

91.74%-391K

-579.63%-367K

Depreciation and amortization

0.66%7.37M

8.41%7.61M

13.10%7.89M

23.97%32.13M

62.10%10.81M

13.53%7.33M

8.79%7.02M

9.96%6.98M

9.44%25.92M

5.11%6.67M

Deferred tax

11.96%2.65M

194.12%160K

-1.49%2.38M

-27.58%16.8M

48.71%12.19M

223.02%2.37M

-102.99%-170K

-78.52%2.42M

160.40%23.2M

225.41%8.2M

Other non cash items

----

---15.29M

----

Change In working capital

197.95%4.64M

136.92%30.15M

89.74%-8.85M

86.41%-37.91M

745.92%40.27M

97.89%-4.73M

113.84%12.73M

-296.97%-86.17M

-160.57%-279.03M

-108.05%-6.24M

-Change in receivables

-70.50%-2.64M

139.16%56.1M

-22.85%-24.31M

440.09%39.72M

426.30%37.6M

89.36%-1.55M

15.61%23.46M

-235.79%-19.79M

-317.99%-11.68M

-205.48%-11.52M

-Change in inventory

6.50%-6.59M

-389.68%-3.62M

434.71%21.98M

-717.88%-16.92M

-5,465.88%-4.56M

-1,561.62%-7.05M

1,938.24%1.25M

-155.69%-6.57M

92.40%-2.07M

100.79%85K

-Change in payables and accrued expense

259.20%13.87M

-86.36%-22.32M

89.11%-6.51M

77.12%-60.71M

38.95%7.23M

101.83%3.86M

89.32%-11.98M

-214.57%-59.82M

-154.98%-265.28M

-93.27%5.2M

Cash from discontinued investing activities

Operating cash flow

142.23%30.93M

133.37%47.52M

113.40%7.78M

120.01%31.75M

37.31%56.65M

106.65%12.77M

139.14%20.36M

-231.90%-58.03M

-446.73%-158.7M

-19.19%41.26M

Investing cash flow

Cash flow from continuing investing activities

184.91%81.67M

239.23%98.57M

-211.36%-38.7M

26.40%-125.56M

106.15%6.67M

-586.00%-96.19M

-124.56%-70.79M

311.57%34.76M

-351.81%-170.58M

-594.88%-108.61M

Net PPE purchase and sale

-344.65%-34.43M

-411.83%-7.01M

-227.53%-6.79M

82.40%-19.55M

91.79%-8.37M

-135.35%-7.74M

30.72%-1.37M

46.20%-2.07M

-554.04%-111.08M

-3,576.67%-101.95M

Net intangibles purchase and sale

9.26%-49K

102.94%1K

-50.00%-51K

-20.99%-294K

-39.84%-172K

-315.38%-54K

2.86%-34K

52.78%-34K

-50.93%-243K

-179.55%-123K

Net business purchase and sale

----

--0

----

--7.41M

----

Net investment purchase and sale

231.40%116.15M

252.15%105.58M

-186.43%-31.86M

-58.56%-105.71M

209.16%15.21M

-724.65%-88.39M

-135.10%-69.39M

394.90%36.86M

-178.54%-66.67M

-156.28%-13.94M

Cash from discontinued investing activities

Investing cash flow

184.91%81.67M

239.23%98.57M

-211.36%-38.7M

26.40%-125.56M

106.15%6.67M

-586.00%-96.19M

-124.56%-70.79M

311.57%34.76M

-351.81%-170.58M

-594.88%-108.61M

Financing cash flow

Cash flow from continuing financing activities

-3.05%-24.93M

Net common stock issuance

----

--0

----

-3.05%-24.93M

--0

Cash from discontinued financing activities

Financing cash flow

--0

-3.05%-24.93M

--0

Net cash flow

Beginning cash position

53.55%269.01M

-45.01%124.17M

-38.48%154.5M

-58.50%251.13M

-71.09%91.97M

-66.55%175.19M

-63.28%225.8M

-58.50%251.13M

17.89%605.18M

-42.47%318.1M

Current changes in cash

234.97%112.6M

389.66%146.09M

-32.89%-30.93M

73.52%-93.81M

194.03%63.32M

59.49%-83.42M

44.06%-50.43M

-351.68%-23.27M

-496.59%-354.21M

-229.40%-67.35M

Effect of exchange rate changes

288.35%800K

-600.56%-1.24M

128.98%597K

-1,766.47%-2.83M

-311.61%-802K

-47.18%206K

83.35%-177K

-543.97%-2.06M

-93.22%170K

79.62%379K

End cash Position

315.78%382.41M

53.55%269.01M

-45.01%124.17M

-38.48%154.5M

-71.09%91.97M

-66.55%175.19M

-63.28%225.8M

-58.50%251.13M

Free cash flow

-171.49%-3.55M

113.68%40.51M

101.55%933K

104.41%11.9M

179.11%48.11M

102.55%4.97M

135.09%18.96M

-250.09%-60.14M

-1,043.52%-270.02M

-226.10%-60.82M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022	(FY)Mar 31, 2022	(Q4)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	142.23%30.93M	133.37%47.52M	113.40%7.78M	120.01%31.75M	37.31%56.65M	106.65%12.77M	139.14%20.36M	-231.90%-58.03M	-446.73%-158.7M	-19.19%41.26M
Net income from continuing operations	178.08%20.21M	403.87%8.55M	-28.74%10.03M	-56.33%25.45M	-74.78%6.91M	-72.38%7.27M	-112.06%-2.81M	175.02%14.08M	114.54%58.27M	194.88%27.4M
Operating gains losses	-416.67%-741K	89.03%1.16M	-231.81%-953K	714.58%2.4M	327.52%835K	135.19%234K	-56.36%611K	195.26%723K	91.74%-391K	-579.63%-367K
Depreciation and amortization	0.66%7.37M	8.41%7.61M	13.10%7.89M	23.97%32.13M	62.10%10.81M	13.53%7.33M	8.79%7.02M	9.96%6.98M	9.44%25.92M	5.11%6.67M
Deferred tax	11.96%2.65M	194.12%160K	-1.49%2.38M	-27.58%16.8M	48.71%12.19M	223.02%2.37M	-102.99%-170K	-78.52%2.42M	160.40%23.2M	225.41%8.2M
Other non cash items	----	----	----	---15.29M	----	----	----	----	----	----
Change In working capital	197.95%4.64M	136.92%30.15M	89.74%-8.85M	86.41%-37.91M	745.92%40.27M	97.89%-4.73M	113.84%12.73M	-296.97%-86.17M	-160.57%-279.03M	-108.05%-6.24M
-Change in receivables	-70.50%-2.64M	139.16%56.1M	-22.85%-24.31M	440.09%39.72M	426.30%37.6M	89.36%-1.55M	15.61%23.46M	-235.79%-19.79M	-317.99%-11.68M	-205.48%-11.52M
-Change in inventory	6.50%-6.59M	-389.68%-3.62M	434.71%21.98M	-717.88%-16.92M	-5,465.88%-4.56M	-1,561.62%-7.05M	1,938.24%1.25M	-155.69%-6.57M	92.40%-2.07M	100.79%85K
-Change in payables and accrued expense	259.20%13.87M	-86.36%-22.32M	89.11%-6.51M	77.12%-60.71M	38.95%7.23M	101.83%3.86M	89.32%-11.98M	-214.57%-59.82M	-154.98%-265.28M	-93.27%5.2M
Cash from discontinued investing activities
Operating cash flow	142.23%30.93M	133.37%47.52M	113.40%7.78M	120.01%31.75M	37.31%56.65M	106.65%12.77M	139.14%20.36M	-231.90%-58.03M	-446.73%-158.7M	-19.19%41.26M
Investing cash flow
Cash flow from continuing investing activities	184.91%81.67M	239.23%98.57M	-211.36%-38.7M	26.40%-125.56M	106.15%6.67M	-586.00%-96.19M	-124.56%-70.79M	311.57%34.76M	-351.81%-170.58M	-594.88%-108.61M
Net PPE purchase and sale	-344.65%-34.43M	-411.83%-7.01M	-227.53%-6.79M	82.40%-19.55M	91.79%-8.37M	-135.35%-7.74M	30.72%-1.37M	46.20%-2.07M	-554.04%-111.08M	-3,576.67%-101.95M
Net intangibles purchase and sale	9.26%-49K	102.94%1K	-50.00%-51K	-20.99%-294K	-39.84%-172K	-315.38%-54K	2.86%-34K	52.78%-34K	-50.93%-243K	-179.55%-123K
Net business purchase and sale	----	----	----	--0	----	----	----	----	--7.41M	----
Net investment purchase and sale	231.40%116.15M	252.15%105.58M	-186.43%-31.86M	-58.56%-105.71M	209.16%15.21M	-724.65%-88.39M	-135.10%-69.39M	394.90%36.86M	-178.54%-66.67M	-156.28%-13.94M
Cash from discontinued investing activities
Investing cash flow	184.91%81.67M	239.23%98.57M	-211.36%-38.7M	26.40%-125.56M	106.15%6.67M	-586.00%-96.19M	-124.56%-70.79M	311.57%34.76M	-351.81%-170.58M	-594.88%-108.61M
Financing cash flow
Cash flow from continuing financing activities				0					-3.05%-24.93M	0
Net common stock issuance	----	----	----	--0	----	----	----	----	-3.05%-24.93M	--0
Cash from discontinued financing activities
Financing cash flow	--0	--0	--0	--0	--0	--0	--0	--0	-3.05%-24.93M	--0
Net cash flow
Beginning cash position	53.55%269.01M	-45.01%124.17M	-38.48%154.5M	-58.50%251.13M	-71.09%91.97M	-66.55%175.19M	-63.28%225.8M	-58.50%251.13M	17.89%605.18M	-42.47%318.1M
Current changes in cash	234.97%112.6M	389.66%146.09M	-32.89%-30.93M	73.52%-93.81M	194.03%63.32M	59.49%-83.42M	44.06%-50.43M	-351.68%-23.27M	-496.59%-354.21M	-229.40%-67.35M
Effect of exchange rate changes	288.35%800K	-600.56%-1.24M	128.98%597K	-1,766.47%-2.83M	-311.61%-802K	-47.18%206K	83.35%-177K	-543.97%-2.06M	-93.22%170K	79.62%379K
End cash Position	315.78%382.41M	53.55%269.01M	-45.01%124.17M	-38.48%154.5M	-38.48%154.5M	-71.09%91.97M	-66.55%175.19M	-63.28%225.8M	-58.50%251.13M	-58.50%251.13M
Free cash flow	-171.49%-3.55M	113.68%40.51M	101.55%933K	104.41%11.9M	179.11%48.11M	102.55%4.97M	135.09%18.96M	-250.09%-60.14M	-1,043.52%-270.02M	-226.10%-60.82M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall